Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies Disease

NCT02298829 · clinicaltrials.gov ↗

COMPLETED

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Peyronie's Disease

Interventions

DRUG: Subjects Previously Treated with AA4500

Sponsor

Endo Pharmaceuticals